These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 32908786)
1. LncRNA DLG1-AS1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Downregulating miR-203. Li S J Breast Cancer; 2020 Aug; 23(4):343-354. PubMed ID: 32908786 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 overexpression inhibits the proliferation of cancer cells by reducing RUNX2 expression in triple-negative breast cancer. Wei M; Liu L; Wang Z Oncol Lett; 2019 Dec; 18(6):6775-6780. PubMed ID: 31788122 [TBL] [Abstract][Full Text] [Related]
3. MiR-526b targets lncRNA SLC16A1-AS1 to suppress cell proliferation in triple-negative breast cancer. Zhao X; Fu L; Zhai L; Yang X; Gao R J Biochem Mol Toxicol; 2023 Mar; 37(3):e23247. PubMed ID: 36654514 [TBL] [Abstract][Full Text] [Related]
4. PBX3-activated DLG1-AS1 can promote the proliferation, invasion, and migration of TNBC cells by sponging miR-16-5p. Zhang H; Shi X; Ge Z; Wang Z; Gao Y; Gao G; Xu W; Qu X Mol Ther Oncolytics; 2022 Jun; 25():201-210. PubMed ID: 35592389 [TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA Tang L; Chen Y; Tang X; Wei D; Xu X; Yan F J Cancer; 2020; 11(2):311-323. PubMed ID: 31897227 [No Abstract] [Full Text] [Related]
6. Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients' survival by downregulating miR-21. Gao J; Wang S; Zhang Z; Li J BMC Cancer; 2021 Jun; 21(1):745. PubMed ID: 34182945 [TBL] [Abstract][Full Text] [Related]
7. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer. Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449 [TBL] [Abstract][Full Text] [Related]
8. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy. Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923 [TBL] [Abstract][Full Text] [Related]
9. lncRNA DLG1-AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR-16-5p/HDGF. Zou MJ; Cheng XR; Liu RF J Obstet Gynaecol Res; 2022 Jul; 48(7):1836-1847. PubMed ID: 35388952 [TBL] [Abstract][Full Text] [Related]
10. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle. Jiang B; Liu Q; Gai J; Guan J; Li Q Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):534-540. PubMed ID: 35316129 [TBL] [Abstract][Full Text] [Related]
11. lncRNA DLG1-AS1 Promotes Cell Proliferation by Competitively Binding with miR-107 and Up-Regulating ZHX1 Expression in Cervical Cancer. Rui X; Xu Y; Huang Y; Ji L; Jiang X Cell Physiol Biochem; 2018; 49(5):1792-1803. PubMed ID: 30231238 [TBL] [Abstract][Full Text] [Related]
12. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis. Han C; Fu Y; Zeng N; Yin J; Li Q Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway. Qiao Y; Wang B; Yan Y; Niu L Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485 [TBL] [Abstract][Full Text] [Related]
14. LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis. Li P; Zeng Y; Chen Y; Huang P; Chen X; Zheng W Cancer Cell Int; 2022 Mar; 22(1):116. PubMed ID: 35279146 [TBL] [Abstract][Full Text] [Related]
15. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules. He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630 [TBL] [Abstract][Full Text] [Related]
16. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54. Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336 [TBL] [Abstract][Full Text] [Related]
17. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression. Zhang X; Zhou Y; Mao F; Lin Y; Shen S; Sun Q Sci Rep; 2020 May; 10(1):7662. PubMed ID: 32376943 [TBL] [Abstract][Full Text] [Related]
18. LncRNA MCM3AP-AS1 Downregulates LncRNA MEG3 in Triple Negative Breast Cancer to Inhibit the Proliferation of Cancer Cells. Ren G; Han G; Song Z; Zang A; Liu B; Hu L; Jia L; Hong D; Yang L; Qie S Crit Rev Eukaryot Gene Expr; 2021; 31(4):81-87. PubMed ID: 34587438 [TBL] [Abstract][Full Text] [Related]
19. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD. Wu D; Jia H; Zhang Z; Li S Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253 [TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer. Lv Y; Lv X; Yang H; Qi X; Wang X; Li C; Shang X; Guo H; Zhang J; Zhang Y Front Oncol; 2021; 11():678474. PubMed ID: 34026654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]